ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,705,720, issued on Aug. 11, was assigned to Modicus Prime Ltd..

"Self-trainable neural network application for anomaly detection of biopharmaceutical products" was invented by Taylor Chartier (La Porte, Ind.), Vitaliy Kucheryaviy (La Porte, Ind.) and David Vardanyan (La Porte, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "System for analyzing anomalies in pharmaceuticals includes a server configured to host a neural network having an inference engine and a training engine, a database of images of in-process biologics; a first user interface module for displaying to a user particle morphologies in the images; a second user interface module for disp...